• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Dominari Holdings Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    9/22/25 8:05:34 AM ET
    $DOMH
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $DOMH alert in real time by email
    false 0000012239 0000012239 2025-09-21 2025-09-21 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 8-K

     

    CURRENT REPORT

    Pursuant to Section 13 or Section 15(d)

    of the Securities Exchange Act of 1934

     

    Date of Report (Date of earliest event reported): September 21, 2025

     

    Dominari Holdings Inc.

    (Exact name of registrant as specified in its charter)

     

    Delaware   000-41845   52-0849320
    (State or other jurisdiction
    of incorporation)
      (Commission File Number)   (IRS Employer
    Identification No.)

     

    725 5th Avenue, 23rd Floor

    New York, NY 10022

    (212) 393-4540

    (Address, including Zip Code and Telephone Number, including

    Area Code, of Principal Executive Offices)

     

    Not Applicable

    (Former name or former address, if changed since last report)

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation to the registrant under any of the following provisions:

     

    ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

    ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

    ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

    ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class   Trading Symbol(s)   Name of each exchange on which registered
    Common Stock, $0.0001 par value   DOMH   The Nasdaq Capital Market

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

     

    Emerging growth company ☐

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     

     

     

     

     

    Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

     

    CFO Appointment; Resignation of Tim Ledwick as a Director

     

    Effective as of October 1, 2025, Tim Ledwick, 67, was appointed as the Chief Financial Officer of Dominari Holdings Inc. (the “Company”). Mr. Ledwick served as the Audit Committee Chair of the Company since 2015. Most recently, he provided CFO consulting services to a Nasdaq listed public safety technology and services company (Nasdaq: WRAP). From 2011 until 2022, he was the Chief Financial Officer of SYFT, a private equity-backed company that provided software solutions and services to hospitals focused on reducing costs which was successfully sold to GHX in 2022. In addition, since 2012 he has served on the board of directors and Audit Committee Chair of Telkonet, Inc. (Nasdaq: TKOI), a smart energy management technology company. From 2007 to 2011, Mr. Ledwick provided CFO consulting services to a $150 million services firm and from 2002 through 2006, he was a member of the board of directors and Executive Vice President-CFO of Dictaphone Corporation playing a lead role in developing a business plan which revitalized the company, resulting in the successful sale of the firm delivering a seven times return to shareholders. From 2001-2002, Mr. Ledwick was brought on as CFO to lead the restructuring efforts of Lernout & Hauspie Speech Products (“L&H”), a Belgium-based Nasdaq listed speech technology company, whose market cap had at one point reached a high of $9 billion. Prior to L&H, he held CFO positions at Cross Media Marketing Corp and Cityscape Financial Corp. He began his career at Peat, Marwick, Mitchell & Co. Mr. Ledwick is a member of the Connecticut Society of Certified Public Accountants and received his BBA in Accounting from The George Washington University and his MS in Finance from Fairfield University.

     

    He has no family relationship with any of the executive officers or directors of the Company. There are no arrangements or understandings between Mr. Ledwick and any other person pursuant to which he was appointed as an officer of the Company.

     

    In accordance with the terms of Mr. Ledwick’s Employment Agreement with the Company, dated as of September 21, 2025 (the “Employment Agreement”), he will serve as the Company’s Chief Financial Officer for an initial term of one (1) year, which term will be automatically renewed for additional one-year periods unless either party timely delivers a non-renewal notice. Mr. Ledwick’s base salary is $350,000 per year, subject to regular annual review, payable in accordance with the standard payroll practices of the Company, and subject to all withholdings and deductions, as required by law. The Employment Agreement also provides that the Company will recommend to the board of directors that it make a grant of restricted stock to Mr. Ledwick in an amount equal to 2.0% of the Company’s outstanding common stock, with terms and conditions to be decided at the time of grant. This restricted stock award has not yet been granted. Mr. Ledwick is also entitled to an annual bonus, as determined by the Company’s board of directors in its sole discretion, provided that such annual bonus will not be less than $175,000 in the initial term. Annual bonuses and all stock-based compensation are subject to certain clawback rights as provided in the Employment Agreement.

     

    Mr. Ledwick is also entitled to the payment or reimbursement of all reasonable out-of-pocket expenses. Pursuant to the terms of the Employment Agreement, Mr. Ledwick is also provided with all health and other benefits provided by the Company to its senior executive employees.

     

    The Employment Agreement also provides for customary events of termination of employment and provides that in the event of termination as a result of Mr. Ledwick’s death or disability, Mr. Ledwick is entitled to severance consisting of (i) six (6) months of his then current base salary; (ii) payment on a pro-rated basis of an annual bonus for the year of termination (which shall be deemed to equal 50% of his then current base salary); (iii) any unpaid annual bonus earned for the prior year; and (iv) any other payments earned in connection with any bonus plan to which Mr. Ledwick was a participant as of the date of death or disability. In the event of termination of Mr. Ledwick’s employment (i) by Mr. Ledwick, for Good Reason (as such term is defined in the Employment Agreement), or (ii) by the Company, without Cause (as such term is defined in the Employment Agreement), then Mr. Ledwick is entitled to (i) six (6) months of his then current base salary; (ii) payment on a pro-rated basis of an annual bonus for the year of termination (which shall be deemed to equal 100% of his then current base salary); (iii) any unpaid annual bonus earned for the prior year; (iv) any other payments earned in connection with any bonus plan to which Mr. Ledwick was a participant as of the date of termination; and (v) full accelerated vesting on any equity grants held by Mr. Ledwick at his termination..

     

    The above description of the Employment Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Employment Agreement filed herewith as Exhibit 10.1.

     

    Tim Ledwick notified the Company of his decision to resign as a member of the board of directors of the Company, effective as of September 21, 2025. Mr. Ledwick’s resignation is not due to any disagreements with the Company on any of its operations, policies or practices.

     

    Item 9.01. Financial Statements and Exhibits.

     

    Set forth below is a list of Exhibits included as part of this Current Report.

     

    Exhibit No.   Description
    10.1*   Employment Agreement, made and entered into as of September 21, 2025, by and between Dominari Holdings Inc. and Tim Ledwick
    104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

     

    1

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

    Dated: September 22, 2025 DOMINARI HOLDINGS INC.
         
      By: /s/ Anthony Hayes
      Name:  Anthony Hayes
      Title: Chief Executive Officer

     

    2

     

    Get the next $DOMH alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $DOMH

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $DOMH
    SEC Filings

    View All

    Dominari Holdings Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - Dominari Holdings Inc. (0000012239) (Filer)

    9/22/25 8:05:34 AM ET
    $DOMH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Dominari Holdings Inc. filed SEC Form 8-K: Leadership Update

    8-K - Dominari Holdings Inc. (0000012239) (Filer)

    9/10/25 8:00:30 AM ET
    $DOMH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form S-3 filed by Dominari Holdings Inc.

    S-3 - Dominari Holdings Inc. (0000012239) (Filer)

    8/28/25 8:01:40 AM ET
    $DOMH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $DOMH
    Leadership Updates

    Live Leadership Updates

    View All

    $DOMH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Dominari Securities Appoints Communications and Growth Strategist Brian Parsley to Board

    Accomplished entrepreneur and global speaker to strengthen firm's marketing, investor engagement and strategic communications to help drive growth NEW YORK, Sept. 10, 2025 /PRNewswire/ -- Dominari Holdings Inc. (NASDAQ:DOMH), today announced the appointment of Brian Parsley to its Board of Directors. Parsley, an accomplished entrepreneur, behavioral analyst and internationally recognized speaker, will support the firm's growth by enhancing its marketing, investor outreach and overall communications strategy. Mr. Parsley has more than 30 years of experience in entrepreneurship,

    9/10/25 8:30:00 AM ET
    $DOMH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Dominari Holdings Set to Join Russell Microcap® Index

    NEW YORK, May 28, 2025 /PRNewswire/ -- Dominari Holdings Inc. (NASDAQ:DOMH), is set to join the Russell Microcap® Index at the conclusion of the 2025 Russell indexes annual reconstitution, effective after the US market opens on June 30, according to a preliminary list of additions posted May 23. The annual Russell US Indexes reconstitution captures the 4,000 largest US stocks as of Wednesday, April 30, ranking them by total market capitalization. Membership in the Russell Microcap® Index, which remains in place for one year, means automatic inclusion in the appropriate growth

    5/28/25 8:30:00 AM ET
    $DOMH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Dominari Holdings Inc. Strengthens Team with Appointment of Experienced Accounting Team

    Edward Deignan Appointed as VP of Finance and Accounting Kyle Degruttola Appointed as Controller NEW YORK, NY / ACCESSWIRE / November 11, 2024 / Dominari Holdings Inc. (NASDAQ:DOMH) (the "Company") today announced that it has appointed Edward Deignan as Vice President of Finance and Accounting and Kyle Degruttola as Controller. Together, they bring decades of accounting and finance leadership experience from various multi-national and public sector organizations.Mr. Deignan is responsible for the day-to-day management of the Company's financial operations. He brings with him more than 30 years of experience in accounting, finance and banking. He has served as a chief financial officer for s

    11/11/24 8:00:00 AM ET
    $DOMH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 3 filed by new insider Parsley Brian Keith

    3 - Dominari Holdings Inc. (0000012239) (Issuer)

    9/29/25 4:30:02 PM ET
    $DOMH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Blattner Gregory James sold 14,409 shares, decreasing direct ownership by 39% to 22,411 units (SEC Form 4)

    4 - Dominari Holdings Inc. (0000012239) (Issuer)

    9/25/25 5:00:02 PM ET
    $DOMH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    CEO Hayes Anthony gifted 15,000 shares, decreasing direct ownership by 0.92% to 1,614,566 units (SEC Form 4)

    4 - Dominari Holdings Inc. (0000012239) (Issuer)

    5/6/25 4:15:04 PM ET
    $DOMH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $DOMH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Dominari Holdings Announces Board Member Tim Ledwick to Assume Role of Interim Chief Financial Officer

    NEW YORK, Sept. 23, 2025 /PRNewswire/ -- Dominari Holdings Inc. (NASDAQ:DOMH), today announced that Tim Ledwick, a current member of the Company's Board of Directors, has stepped down from the Board to serve as Interim Chief Financial Officer, beginning October 1, 2025. "Tim has extensive experience leading financial operations across multiple industries," said Anthony Hayes, Chief Executive Officer of Dominari Holdings. "His background spans public and private companies, with expertise in restructuring, capital markets, M&A, and operational turnarounds. As Interim Chief Finan

    9/23/25 8:00:00 AM ET
    $DOMH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Dominari Securities Appoints Communications and Growth Strategist Brian Parsley to Board

    Accomplished entrepreneur and global speaker to strengthen firm's marketing, investor engagement and strategic communications to help drive growth NEW YORK, Sept. 10, 2025 /PRNewswire/ -- Dominari Holdings Inc. (NASDAQ:DOMH), today announced the appointment of Brian Parsley to its Board of Directors. Parsley, an accomplished entrepreneur, behavioral analyst and internationally recognized speaker, will support the firm's growth by enhancing its marketing, investor outreach and overall communications strategy. Mr. Parsley has more than 30 years of experience in entrepreneurship,

    9/10/25 8:30:00 AM ET
    $DOMH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Dominari Holdings Applauds American Bitcoin's Nasdaq Debut; Highlights Strategic Stake

    Dominari Holdings Inc. Holds Approximately 23,199,205 Shares of American Bitcoin (NASDAQ:ABTC), Valued at Approximately $170 Million at ABTC's September 5, 2025 Close NEW YORK, Sept. 9, 2025 /PRNewswire/ -- Dominari Holdings Inc. (NASDAQ:DOMH) ("Dominari" or the "Company") (NASDAQ:DOMH) today congratulated American Bitcoin ("ABTC") on its successful listing on the Nasdaq Stock Market. Dominari holds approximately 23,199,205 shares of ABTC. Based on ABTC's closing price of $7.40 per share on September 5, 2025, Dominari's position had an approximate market value of $171,674,117 at the time of that close.

    9/9/25 8:00:00 AM ET
    $ABTC
    $DOMH
    EDP Services
    Technology
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $DOMH
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Ledwick Tim S bought 8,645 shares and was granted 10,000 shares, increasing direct ownership by 145% to 31,471 units (SEC Form 4)

    4 - Dominari Holdings Inc. (0000012239) (Issuer)

    2/12/25 5:03:10 PM ET
    $DOMH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Lieberman Ronald J. bought 21,613 shares and was granted 10,000 shares (SEC Form 4)

    4 - Dominari Holdings Inc. (0000012239) (Issuer)

    2/12/25 5:00:46 PM ET
    $DOMH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    President Wool Kyle Michael bought 288,184 shares, increasing direct ownership by 15% to 2,200,769 units (SEC Form 4)

    4 - Dominari Holdings Inc. (0000012239) (Issuer)

    2/12/25 4:58:43 PM ET
    $DOMH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $DOMH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Dominari Holdings Inc.

    SC 13D/A - Dominari Holdings Inc. (0000012239) (Subject)

    6/13/24 8:56:04 PM ET
    $DOMH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by Dominari Holdings Inc.

    SC 13D/A - Dominari Holdings Inc. (0000012239) (Subject)

    6/13/24 4:32:07 PM ET
    $DOMH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $DOMH
    Financials

    Live finance-specific insights

    View All

    Dominari Holdings Announces Record Date for Cash Dividend

    NEW YORK, Aug. 22, 2025 /PRNewswire/ -- Dominari Holdings Inc. (NASDAQ:DOMH) is pleased to announce that its board of directors has authorized a special cash dividend of, in the aggregate, approximately $5 million, or $0.22 per share. The dividend is expected to be payable on or around September 26, 2025, to DOMH's shareholders and certain DOMH warrant holders (on an as-exercised basis) of record as of the close of business on September 3, 2025. For additional information about Dominari Holdings Inc., please visit: https://www.dominariholdings.com/ About Dominari Holdings Inc.

    8/22/25 9:15:00 AM ET
    $DOMH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Dominari Marks Inflection Point with Second Quarter 2025 Financial Results

    Revenue of $34.1 Million, up 520%Closed 46 Transactions in Q2 with Total Raise Amount of More Than $288.9 Million between both our Private & Public TransactionsNEW YORK, Aug. 12, 2025 /PRNewswire/ -- Dominari Holdings Inc. (NASDAQ:DOMH), today announced financial results for the quarter that ended June 30, 2025. The results underscore a significant inflection point for the Company, which delivered breakout performance during the quarter. "This quarter marks a turning point for Dominari," said Anthony Hayes, Chief Executive Officer of Dominari Holdings. "Revenue reached $34.1 m

    8/12/25 9:15:00 AM ET
    $DOMH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Dominari Holdings Investment, American Data Centers, Becomes American Bitcoin in Transformative Bitcoin Mining Deal with Hut 8

    Dominari Executing Expansion Strategy with Investment in Industrial Scale Bitcoin Mining and Bitcoin Reserve Development  NEW YORK, March 31, 2025 /PRNewswire/ -- Dominari Holdings Inc. (NASDAQ:DOMH) today announced that American Data Centers Inc. ("ADC") and Hut 8 Corp, ("Hut") partnered to form American Bitcoin Corporation.  As previously announced, ADC was a wholly owned subsidiary of Dominari, but became an independent company, whose members include Donald J. Trump Jr., Eric Trump, Dominari and other industry professionals in the AI space.  In partnership with Hut, American Bitcoin Corp., will focus on industrial-scale bitcoin mining and strategic bitcoin reserve development and monetiza

    3/31/25 8:00:00 AM ET
    $DOMH
    Biotechnology: Pharmaceutical Preparations
    Health Care